Thar Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Thar Pharmaceuticals Ownership

Who owns Thar Pharmaceuticals?

Thar Pharmaceuticals is owned by Grünenthal. It was acquired on November 16, 2016.

Thar Pharmaceuticals Business Overview

Where is Thar Pharmaceuticals headquartered?

Thar Pharmaceuticals is headquartered in Pittsburgh, Pennsylvania.

How many employees does Thar Pharmaceuticals have?

Thar Pharmaceuticals has 4 employees.

What sector is Thar Pharmaceuticals in?

Thar Pharmaceuticals is a life science company.

When was Thar Pharmaceuticals founded?

Thar Pharmaceuticals was founded in 2006.

Life Science M&A Summary in 2016

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.

Join Mergr to view all 293 acquisitions of life science companies in 2016, including 32 acquisitions by private equity firms, and 261 by strategics.

Thar Pharmaceuticals, Inc.

150 Gamma Drive,
Pittsburgh, Pennsylvania 15238
United States,
(412) 963-6800
www.tharpharma.com

Thar Pharmaceuticals, Inc. is a pharmaceutical company. Thar Pharmaceuticals focused on transforming IV-only drugs into oral drugs for existing and new indications using its proprietary technology EnhanceTM development platform.


 Subscribe to unlock this and 206,228
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.